E. L. Sitkina
Research Subjects
E. L. Sitkina has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Regina A. Ivanova
Federal Research and Clinical Center for Infectious Diseases under the Federal Medical Biological Agency
2 shared publications A.D. Savina
1 shared publication- Anatoly I. Khavkin
Research Clinical Institute of Childhood; Belgorod State National Research University
1 shared publication - Dmitriy A. Lioznov
Smorodintsev Research Institute of Influenza, 197022 Saint Petersburg, Russia
1 shared publication I.M. Kosenko
1 shared publication- Stanislav I. Sitkin
Almazov National Medical Research Centre; North-Western State Medical University named after I.I. Mechnikov; Institute of Experimental Medicine
1 shared publication
Latest Publications
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 20 (1)
Acute norovirus gastroenteritis: epidemiology, clinical features, treatment and prevention
Achievements in the coverage of the child population with rotavirus vaccination in many countries have led to the fact that norovirus infection (NVI) is rapidly leading to the incidence of acute intestinal infections. NVI affects not only children but also the elderly, as well as patients with reduced immunity. NVI leads to a large number of hospitalizations and deaths, even though, in general, outbreaks of norovirus gastroenteritis are not severe and self-limited. Nevertheless, NVI's social and economic burden cannot be underestimated due to its ability to spread quickly and involve many patients, causing outbreaks in social institutions, schools, hospitals, and nursing homes. Thus 2023, 269 foci of group incidence of NVI were registered in the Russian Federation. The article presents the latest data on the epidemiology of NVI and the prevalence of norovirus genotypes; in particular, a sharp increase in the GII.17 genotype is noted. It is emphasized that the constant change in the genetic diversity of noroviruses and the emergence of new recombinant variants is a global trend that significantly complicates the creation of effective vaccines. Up-to-date information on the diagnosis and differential diagnosis of NVI is presented. The treatment section is devoted to all aspects of therapy and is based on the latest international and national clinical guidelines. The lack of causal therapy for NVI and the importance of timely administration of pathogenetic treatment, including probiotics, are emphasized. Data from experimental and clinical studies have shown that some probiotic strains, such as Saccharomyces boulardii CNCM I-745, which have an indirect antiviral effect, can significantly reduce the duration of diarrhea in children with acute gastroenteritis and the duration of hospitalization. The prospects for the development of various types of vaccines against norovirus are discussed, including vaccines based on non-replicating virus-like particles (VLP), vaccines based on recombinant adenoviruses, vaccines based on P-particles, and mRNA vaccines that form VLP. Prospects in the ongoing fight against NVI are associated with the development of specific methods of prevention (polyvalent vaccines) and treatment (antiviral drugs, microbiomemodulating therapy), the introduction of effective test systems for rapid diagnostics of NVI into routine practice, as well as genetic and immunological studies that will help to establish the subtle mechanisms of susceptibility to norovirus and the characteristics of the immune response to it. Key words: acute norovirus gastroenteritis, norovirus infection, dehydration, rehydration therapy, intestinal microbiome, probiotics, Saccharomyces boulardii CNCM I-745, children
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 20 (1)
Acute norovirus gastroenteritis: epidemiology, clinical features, treatment and prevention
Achievements in the coverage of the child population with rotavirus vaccination in many countries have led to the fact that norovirus infection (NVI) is rapidly leading to the incidence of acute intestinal infections. NVI affects not only children but also the elderly, as well as patients with reduced immunity. NVI leads to a large number of hospitalizations and deaths, even though, in general, outbreaks of norovirus gastroenteritis are not severe and self-limited. Nevertheless, NVI's social and economic burden cannot be underestimated due to its ability to spread quickly and involve many patients, causing outbreaks in social institutions, schools, hospitals, and nursing homes. Thus 2023, 269 foci of group incidence of NVI were registered in the Russian Federation. The article presents the latest data on the epidemiology of NVI and the prevalence of norovirus genotypes; in particular, a sharp increase in the GII.17 genotype is noted. It is emphasized that the constant change in the genetic diversity of noroviruses and the emergence of new recombinant variants is a global trend that significantly complicates the creation of effective vaccines. Up-to-date information on the diagnosis and differential diagnosis of NVI is presented. The treatment section is devoted to all aspects of therapy and is based on the latest international and national clinical guidelines. The lack of causal therapy for NVI and the importance of timely administration of pathogenetic treatment, including probiotics, are emphasized. Data from experimental and clinical studies have shown that some probiotic strains, such as Saccharomyces boulardii CNCM I-745, which have an indirect antiviral effect, can significantly reduce the duration of diarrhea in children with acute gastroenteritis and the duration of hospitalization. The prospects for the development of various types of vaccines against norovirus are discussed, including vaccines based on non-replicating virus-like particles (VLP), vaccines based on recombinant adenoviruses, vaccines based on P-particles, and mRNA vaccines that form VLP. Prospects in the ongoing fight against NVI are associated with the development of specific methods of prevention (polyvalent vaccines) and treatment (antiviral drugs, microbiomemodulating therapy), the introduction of effective test systems for rapid diagnostics of NVI into routine practice, as well as genetic and immunological studies that will help to establish the subtle mechanisms of susceptibility to norovirus and the characteristics of the immune response to it. Key words: acute norovirus gastroenteritis, norovirus infection, dehydration, rehydration therapy, intestinal microbiome, probiotics, Saccharomyces boulardii CNCM I-745, children
- Open Access
- 13 September 2022
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 29 (3) , 118-124
Clinical and laboratory characteristics of haemophilus influenza type b Infection with central nervous system Involvement in young children
Introduction. Invasive Haemophilus influenza type b (Hib) infection often manifests as severe and complicated forms of purulent meningitis in children from birth to 6 years of age. Hib meningitis is the most commonly diagnosed invasive form, with a severe course. There is no generally accepted clinical classification of Hib infection. Along with meningitis, the infection is often manifested with purulent inflammatory foci of different localization.The objective was to characterize the course of purulent Hib meningitis, including in combination with purulent foci, in young children.Methods and materials. We analyzed 45 case histories of children (under the age of 3 years) who had an invasive Haemophilus infection with purulent meningitis. Hib meningitis (Group-1) was diagnosed in 17 patients and meningitis in combination with specific purulent foci was diagnosed in 28 patients (Group-2). The diagnosis in all patients was confirmed bacteriologically or serologically (Latex Agglutination Test).Results. The combination of meningitis with purulent foci of Hib infection was characterized by late hospitalization (36 %), longer recovery of cerebrospinal fluid, longer duration of the disease, and the prevalence of severe and complicated disease, and often required surgical treatment (46.4 %). A burdened premorbid background is traditionally considered a condition for the development of invasive Hib infection. According to our data, only 40 % of children had a burdened premorbid background, which is confirmed by clinical cases.Conclusion. Since Hib infection in young children is often combined with meningitis with purulent foci, is characterized by a severe and complicated course, and often requires surgical treatment, it is advisable to consider this form of infection separately.
- 13 September 2022
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in The Scientific Notes of the Pavlov University
- Vol. 29 (3) , 118-124
Open AccessClinical and laboratory characteristics of haemophilus influenza type b Infection with central nervous system Involvement in young children
Introduction. Invasive Haemophilus influenza type b (Hib) infection often manifests as severe and complicated forms of purulent meningitis in children from birth to 6 years of age. Hib meningitis is the most commonly diagnosed invasive form, with a severe course. There is no generally accepted clinical classification of Hib infection. Along with meningitis, the infection is often manifested with purulent inflammatory foci of different localization.The objective was to characterize the course of purulent Hib meningitis, including in combination with purulent foci, in young children.Methods and materials. We analyzed 45 case histories of children (under the age of 3 years) who had an invasive Haemophilus infection with purulent meningitis. Hib meningitis (Group-1) was diagnosed in 17 patients and meningitis in combination with specific purulent foci was diagnosed in 28 patients (Group-2). The diagnosis in all patients was confirmed bacteriologically or serologically (Latex Agglutination Test).Results. The combination of meningitis with purulent foci of Hib infection was characterized by late hospitalization (36 %), longer recovery of cerebrospinal fluid, longer duration of the disease, and the prevalence of severe and complicated disease, and often required surgical treatment (46.4 %). A burdened premorbid background is traditionally considered a condition for the development of invasive Hib infection. According to our data, only 40 % of children had a burdened premorbid background, which is confirmed by clinical cases.Conclusion. Since Hib infection in young children is often combined with meningitis with purulent foci, is characterized by a severe and complicated course, and often requires surgical treatment, it is advisable to consider this form of infection separately.